Save time and get answers to complex questions with AI chat
Bortezomib market france?Patent expiration eu dabrafenib?Defense strategy against generic in niche market?Alogliptin benzoate cost?Dabrafenib and trametinib cost?
See the DrugPatentWatch profile for Aristada
Aristada is developed by Alkermes in collaboration with Janssen Pharmaceutical Companies (a Johnson & Johnson subsidiary). In the U.S., it’s marketed by Janssen.
Other Questions About Aristada :